{"id":"https://openalex.org/W7166145151","doi":"https://doi.org/10.1111/ijd.70554","title":"Evaluation of Intralesional Bleomycin and Triamcinolone Acetonide in the Treatment of Keloids: A Prospective, Randomized, Open\u2010Label, Comparative Study","display_name":"Evaluation of Intralesional Bleomycin and Triamcinolone Acetonide in the Treatment of Keloids: A Prospective, Randomized, Open\u2010Label, Comparative Study","publication_year":2026,"publication_date":"2026-06-26","ids":{"openalex":"https://openalex.org/W7166145151","doi":"https://doi.org/10.1111/ijd.70554","pmid":"https://pubmed.ncbi.nlm.nih.gov/42360873"},"language":"en","primary_location":{"id":"doi:10.1111/ijd.70554","doi":"https://doi.org/10.1111/ijd.70554","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ijd.70554","pdf_url":null,"source":{"id":"https://openalex.org/S32635664","display_name":"International Journal of Dermatology","issn_l":"0011-9059","issn":["0011-9059","1365-4362","1365-4632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5139411833","display_name":"Divya Ravali Bandaru","orcid":"https://orcid.org/0009-0006-9647-8464","observed_orcids":["https://orcid.org/0009-0006-9647-8464"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Divya Ravali Bandaru","raw_affiliation_strings":["Department of Dermatology Alluri Sitarama Raju Academy of Medical Sciences  Eluru Andhra Pradesh India"],"raw_orcid":"https://orcid.org/0009-0006-9647-8464","affiliations":[{"raw_affiliation_string":"Department of Dermatology Alluri Sitarama Raju Academy of Medical Sciences  Eluru Andhra Pradesh India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060504390","display_name":"Nirupama Bhagya Lakshmi Tatavarthi","orcid":"https://orcid.org/0009-0006-7833-3632","observed_orcids":["https://orcid.org/0009-0006-7833-3632"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nirupama Bhagya Lakshmi Tatavarthi","raw_affiliation_strings":["Department of Dermatology Alluri Sitarama Raju Academy of Medical Sciences  Eluru Andhra Pradesh India"],"raw_orcid":"https://orcid.org/0009-0006-7833-3632","affiliations":[{"raw_affiliation_string":"Department of Dermatology Alluri Sitarama Raju Academy of Medical Sciences  Eluru Andhra Pradesh India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139425996","display_name":"Dasika Subba Rao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dasika Subba Rao","raw_affiliation_strings":["Department of Dermatology Alluri Sitarama Raju Academy of Medical Sciences  Eluru Andhra Pradesh India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology Alluri Sitarama Raju Academy of Medical Sciences  Eluru Andhra Pradesh India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060816991","display_name":"Ramala Amala","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ramala Amala","raw_affiliation_strings":["Department of Dermatology Alluri Sitarama Raju Academy of Medical Sciences  Eluru Andhra Pradesh India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology Alluri Sitarama Raju Academy of Medical Sciences  Eluru Andhra Pradesh India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5139411833"],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":6.3998,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.96097644,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"65","issue":"11","first_page":"2334","last_page":"2342"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10771","display_name":"Wound Healing and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2742","display_name":"Rehabilitation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/keloids","display_name":"keloids","score":0.9850000143051147},{"id":"https://openalex.org/keywords/intralesional-bleomycin","display_name":"intralesional bleomycin","score":0.9660000205039978},{"id":"https://openalex.org/keywords/intralesional-triamcinolone-acetonide","display_name":"intralesional triamcinolone","score":0.9559999704360962},{"id":"https://openalex.org/keywords/scar-reduction","display_name":"scar reduction","score":0.6240000128746033},{"id":"https://openalex.org/keywords/vancouver-scar-scale","display_name":"Vancouver Scar Scale","score":0.8769999742507935},{"id":"https://openalex.org/keywords/scar-height","display_name":"scar height","score":0.671999990940094},{"id":"https://openalex.org/keywords/treatment-side-effects","display_name":"treatment side effects","score":0.6000000238418579},{"id":"https://openalex.org/keywords/hyperpigmentation","display_name":"hyperpigmentation","score":0.878000020980835},{"id":"https://openalex.org/keywords/telangiectasia","display_name":"telangiectasia","score":0.8579999804496765},{"id":"https://openalex.org/keywords/skin-atrophy","display_name":"skin atrophy","score":0.7910000085830688},{"id":"https://openalex.org/keywords/collagen-deposition","display_name":"collagen deposition","score":0.6129999756813049},{"id":"https://openalex.org/keywords/treatment-response-rate","display_name":"treatment response rate","score":0.5569999814033508},{"id":"https://openalex.org/keywords/risk-of-recurrence","display_name":"recurrence risk","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9656999707221985},{"id":"https://openalex.org/C2778903070","wikidata":"https://www.wikidata.org/wiki/Q2211240","display_name":"Triamcinolone acetonide","level":2,"score":0.9199000000953674},{"id":"https://openalex.org/C2776232574","wikidata":"https://www.wikidata.org/wiki/Q415571","display_name":"Bleomycin","level":3,"score":0.7609999775886536},{"id":"https://openalex.org/C2777642821","wikidata":"https://www.wikidata.org/wiki/Q206060","display_name":"Scars","level":2,"score":0.6464999914169312},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6011000275611877},{"id":"https://openalex.org/C2776330896","wikidata":"https://www.wikidata.org/wiki/Q1634800","display_name":"Telangiectasia","level":2,"score":0.5921000242233276},{"id":"https://openalex.org/C2776728111","wikidata":"https://www.wikidata.org/wiki/Q1641068","display_name":"Hyperpigmentation","level":2,"score":0.551800012588501},{"id":"https://openalex.org/C2777538232","wikidata":"https://www.wikidata.org/wiki/Q1131260","display_name":"Keloid","level":2,"score":0.5317999720573425},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.46700000762939453},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.46650001406669617},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.38920000195503235},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.3743000030517578},{"id":"https://openalex.org/C2781172350","wikidata":"https://www.wikidata.org/wiki/Q194520","display_name":"Atrophy","level":2,"score":0.3630000054836273},{"id":"https://openalex.org/C2780269544","wikidata":"https://www.wikidata.org/wiki/Q1509074","display_name":"Wound healing","level":2,"score":0.35350000858306885},{"id":"https://openalex.org/C2993807428","wikidata":"https://www.wikidata.org/wiki/Q25324087","display_name":"Wound care","level":2,"score":0.321399986743927},{"id":"https://openalex.org/C2777501473","wikidata":"https://www.wikidata.org/wiki/Q1796666","display_name":"Body surface area","level":2,"score":0.3199000060558319},{"id":"https://openalex.org/C2909381827","wikidata":"https://www.wikidata.org/wiki/Q1641068","display_name":"Skin hyperpigmentation","level":3,"score":0.3151000142097473},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28439998626708984},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.2757999897003174},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.2628999948501587},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2533000111579895},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25200000405311584}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007627","descriptor_name":"Keloid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007627","descriptor_name":"Keloid","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014222","descriptor_name":"Triamcinolone Acetonide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014222","descriptor_name":"Triamcinolone Acetonide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014222","descriptor_name":"Triamcinolone Acetonide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015552","descriptor_name":"Injections, Intralesional","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/ijd.70554","doi":"https://doi.org/10.1111/ijd.70554","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ijd.70554","pdf_url":null,"source":{"id":"https://openalex.org/S32635664","display_name":"International Journal of Dermatology","issn_l":"0011-9059","issn":["0011-9059","1365-4362","1365-4632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:42360873","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42360873","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of dermatology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7785549163818359}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1476610668","https://openalex.org/W2005530413","https://openalex.org/W2010213275","https://openalex.org/W2057467361","https://openalex.org/W2067788386","https://openalex.org/W2792079960","https://openalex.org/W2802228243","https://openalex.org/W2810418132","https://openalex.org/W2912552414","https://openalex.org/W3006103383","https://openalex.org/W3121928634","https://openalex.org/W3126415555","https://openalex.org/W3183682890","https://openalex.org/W4210728529","https://openalex.org/W4235363022","https://openalex.org/W4285520799","https://openalex.org/W4286817117","https://openalex.org/W4312722730","https://openalex.org/W4392621221"],"related_works":[],"abstract_inverted_index":{"BACKGROUND:":[0],"Keloids":[1],"are":[2,280],"benign":[3],"fibroproliferative":[4],"scars":[5],"resulting":[6],"from":[7],"dysregulated":[8],"wound":[9],"healing":[10],"and":[11,91,101,116,172,219,238,267,286],"excessive":[12],"collagen":[13],"deposition.":[14],"Despite":[15],"the":[16,79,86,180,195,209],"availability":[17],"of":[18,143],"multiple":[19],"therapeutic":[20],"options,":[21],"an":[22],"optimal":[23],"treatment":[24],"strategy":[25],"remains":[26],"uncertain.":[27],"METHODS:":[28],"This":[29],"prospective,":[30],"randomized,":[31],"open-label":[32],"comparative":[33],"study":[34],"enrolled":[35],"136":[36],"patients":[37,144],"with":[38,73,146,159,183,229,247,254,276],"clinically":[39],"diagnosed":[40],"keloids,":[41],"who":[42],"were":[43,65,83,94,175,225,244,252],"assigned":[44],"to":[45,189,282],"receive":[46],"either":[47],"intralesional":[48,56],"bleomycin":[49,147,181,259],"(Group":[50,59],"A,":[51],"n":[52,61,153,162],"=":[53,62,154,163,166,199,212,216,222,235,241],"68)":[54],"or":[55],"triamcinolone":[57,133,160,196],"acetonide":[58],"B,":[60],"68).":[63],"Treatments":[64],"administered":[66],"at":[67],"4-week":[68],"intervals":[69],"for":[70],"four":[71],"sessions,":[72],"follow-up":[74,278],"conducted":[75],"2":[76],"months":[77],"after":[78],"final":[80],"session.":[81],"Outcomes":[82],"assessed":[84],"using":[85],"Vancouver":[87],"Scar":[88],"Scale":[89],"(VSS),":[90],"responder":[92],"rates":[93],"defined":[95],"as":[96],"\u2265":[97,99,102,149],"50%,":[98],"75%,":[100],"90%":[103],"reductions":[104],"in":[105,111,123,130,169,179,194,203,263],"VSS.":[106],"Secondary":[107],"outcomes":[108],"included":[109],"changes":[110],"scar":[112,173,186,265],"height,":[113],"surface":[114,204],"area,":[115],"treatment-related":[117],"adverse":[118],"effects.":[119],"RESULTS:":[120],"Bleomycin":[121],"resulted":[122],"a":[124,184],"significantly":[125,177],"greater":[126,178],"mean":[127,185],"percentage":[128],"reduction":[129,202],"VSS":[131],"than":[132,156],"(72.02%":[134],"vs.":[135],"58.10%;":[136],"p":[137,165],"<":[138],"0.00001).":[139],"A":[140],"higher":[141,269],"proportion":[142],"treated":[145,158],"achieved":[148],"75%":[150],"improvement":[151],"(36.8%,":[152],"25/68)":[155],"those":[157],"(14.7%,":[161],"10/68;":[164],"0.0027).":[167],"Improvements":[168],"vascularity,":[170],"pliability,":[171],"height":[174,187],"also":[176],"group,":[182],"reduced":[188],"0.8":[190],"versus":[191],"1.9":[192],"mm":[193],"group":[197],"(p":[198,211],"0.003).":[200],"The":[201],"area":[205],"was":[206],"comparable":[207],"between":[208],"groups":[210],"0.850).":[213],"Pain":[214],"(n":[215,221,234,240],"50,":[217],"74%)":[218],"hyperpigmentation":[220],"18,":[223],"26%)":[224],"more":[226,245],"frequently":[227],"observed":[228],"bleomycin,":[230],"whereas":[231],"skin":[232],"atrophy":[233],"16,":[236],"24%)":[237],"telangiectasia":[239],"15,":[242],"22%)":[243],"common":[246],"triamcinolone.":[248],"CONCLUSION:":[249],"Both":[250],"therapies":[251],"associated":[253],"significant":[255],"clinical":[256],"improvement;":[257],"however,":[258],"demonstrated":[260],"superior":[261],"efficacy":[262],"reducing":[264],"severity":[266],"achieving":[268],"response":[270],"rates.":[271,292],"Larger,":[272],"multicenter,":[273],"blinded":[274],"studies":[275],"longer":[277],"periods":[279],"warranted":[281],"confirm":[283],"these":[284],"findings":[285],"evaluate":[287],"long-term":[288],"outcomes,":[289],"including":[290],"recurrence":[291]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2026-06-27T00:00:00"}